School of Medicine
Showing 1-20 of 24 Results
-
Kelly Bugos MS, ANP-BC, NPD-BC, AOCNP
Affiliate, Central Mgmt-Misc AR
BioKelly Bugos MS, ANP-BC is a Director for the Center for Advanced Practice and a nurse practitioner specializing in cancer survivorship at Stanford Health Care. Ms. Bugos is the Director of Professional Development and the Advanced Practice Provider (APP) Fellowship Program. As director, Ms. Bugos focuses on APP leadership development. Opened in 2016, the APP Fellowship Program educates and trains APPs in transition to professional practice and specialty care, like administration and cancer care. She founded the cancer survivorship clinics at Stanford in 2012 and continues to focus her clinical work on helping people touched by cancer restore their health after treatment. Ms. Bugos has developed other professional roles and programs over her career at Stanford, like the nurse practitioner position in the 1990s. She has expertise in leadership of advanced practice providers, complex patient care in the outpatient setting, long term and late effects of cancer and its treatment, including symptom management. She is a frequent speaker and author on these topics at the regional and national level.
-
Allis Chien
Director, SUMS, Mass Spectrometry Center
Current Role at StanfordDirector, Stanford University Mass Spectrometry (SUMS) core resource laboratory
Staff Director, Stanford School of Medicine Service Centers -
Lisa Henriksen
Associate Professor (Research) of Medicine (Stanford Prevention Research Center)
Sr Research Engineer, Medicine - Stanford Prevention Research CenterCurrent Research and Scholarly InterestsMy research aims to improve our understanding of the health risks associated with exposure to tobacco marketing and provide a scientific rationale for new policies to reduce it. I also study use of media to promote and discourage adolescent tobacco use, and the impact of tobacco advertising on urge and craving to smoke.
-
Ann Hsing
Professor (Research) of Medicine (Stanford Prevention Research Center/Cancer Institute) and of Epidemiology and Population Health
Current Research and Scholarly InterestsResearch Focus
• Epidemiology of prostate, hepatobiliary, and thyroid cancers
• Racial disparities in cancer
• Endogenous hormones/growth factors
• Circadian rhythms
• Chronic inflammation
• Genetic susceptibility
• Cancer prevention and control
• Global oncology and international studies -
Aziz Khan
Senior Research Scientist, Stanford Cancer Institute Core
BioAziz Khan is a sr. staff scientist at the Stanford Cancer Institute, where he develops reproducible pipelines and machine learning methods for integrative analysis of multi-omics data at bulk and single-cell resolution to understand tumor evolution and chromatin regulatory dynamics of tumor growth.
Aziz completed his PhD in Bioinformatics at Tsinghua University, China in 2016 followed by a three year postdoctoral training at the University of Oslo, Norway. During PhD and Postdoc his primary research emphasis was on regulatory genomics and epigenomics. He developed computational methods, tools, and resources to understand the (epi)genomic control of gene regulation in development and disease.
Apart from research, he is advocating for open science, open-source, preprints, and reproducibility in research. He is a contributor for Bioconda and also developed several open-source tools and resources such as JASPAR. He is ASAPbio and eLife Community Ambassador and co-founded ECRcentral (ecrcentral.org), a community initiative for early-career researchers. -
Michaela Kiernan
Sr Research Scholar, Medicine - Med/Stanford Prevention Research Center
Current Research and Scholarly InterestsResearch interests include: (1) the design and testing of targeted behavioral interventions that promote long-term lifestyle changes and weight management among subgroups at risk, and (2) the development of methodological and statistical approaches that improve the design, delivery, and analysis of behavioral randomized clinical trials
-
Jonathan Mulholland
Director, CSIF, School of Medicine - CMGM
Current Role at StanfordDirector of the Cell Sciences Imaging Facility, CSIF
confocal/electron microscopy services
http://microscopy.stanford.edu/
Beckman Center, B050 -
David Solow-Cordero
Associate Director, High-Throughput Screening, Innovative Medicines Accelerator (IMA)
Current Role at StanfordAssociate Director, High-Throughput Screening Knowledge Center, , Sarafan ChEM-H and Innovative Medicine Accelerator (IMA)
This high-throughput screening (HTS) laboratory allows Stanford researchers and others to discover novel modulators of targets that otherwise would not be practical in industry. The center incorporates instrumentation (purchased with NCRR NIH Instrumentation grant numbers S10RR019513, S10RR026338, S10OD025004, and S10OD026899), databases, compound libraries, and personnel whose previous sole domains were in industry.
Among our instrumentation are a fully automated Molecular Devices ImageXpress Micro Confocal High-Content fluorescence microplate imager, with live cell, fluidics and phase contrast options, an Echo 655 Acoustic Dispense, a Thermo integrated HTS robotic system, a Caliper Life Sciences SciClone ALH3000 and an Agilent Bravo microplate liquid handler, and the BMG Clariostarplus, Tecan Infinite M1000 and M1000 PRO and Molecular Devices FlexStation II 384 fluorescence, luminescence and absorbance multimode microplate readers.
We have over 180,000 small molecules for compound screens, 15,000 cDNAs for genomic screens, and whole genome siRNA libraries targeting the human genome (the siARRAY whole human genome siRNA library from Dharmacon, targeting 21,000 human genes) and the mouse genome (Qiagen mouse whole genome siRNA set V1 against 22,124 genes).
The HTSKC main screening lab is located in ChEM-H W008, the cell-based assay development lab is located in CCSR Room 0133-North Wing, between the Transgenic Mouse Facility, and the Stanford Genomics Facility.